The mediating role of metabolic syndrome in cardiovascular diseases

Cardiovascular diseases (CVDs) are a group of heart diseases which is globally considered as a leading cause of mortality and an ultimately huge burden to the economies. In this paper, we propose a new role of the metabolic syndrome (MS) as a mediator of the relationship of CVDs and its socio-demogr...

Full description

Saved in:
Bibliographic Details
Main Authors: Noryanti, Muhammad, Sajid, Mirza Rizwan, Roslinazairimah, Zakaria, Ahmad, Shahbaz
Format: Conference or Workshop Item
Language:English
Published: AIP Publishing 2019
Subjects:
Online Access:http://umpir.ump.edu.my/id/eprint/24712/1/49.1%20The%20mediating%20role%20of%20metabolic%20syndrome%20in%20cardiovascular%20diseases.pdf
http://umpir.ump.edu.my/id/eprint/24712/
https://doi.org/10.1063/1.5121125
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Universiti Malaysia Pahang
Language: English
Description
Summary:Cardiovascular diseases (CVDs) are a group of heart diseases which is globally considered as a leading cause of mortality and an ultimately huge burden to the economies. In this paper, we propose a new role of the metabolic syndrome (MS) as a mediator of the relationship of CVDs and its socio-demographic risk factors. Mediation is a phenomenon which looks simple but methodologically it needs a realistic attention of researchers to investigate the true influence of cause on effect to the variables by splitting its effect into direct and indirect paths. Past studies have mainly investigated the direct paths of social-demographic risk factors between MS and CVDs. In this paper, we discuss direct relationships and uncover the indirect relationship between CVDs and the risk factors. Then, we developed theoretically the mediator role of MS in the relationship of socio-demographic risk factors and CVDs. A comprehensive relationship-based model of social-demographic risk factors, MS and CVDs has been proposed for the future researches. It would help in more precise risk estimation of CVDs and ultimately delay in the onset of fatal CVDs events.